Arcturus Therapeutics Holdings (ARCT) Free Cash Flow (2018 - 2025)
Historic Free Cash Flow for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Q3 2025 value amounting to -$17.3 million.
- Arcturus Therapeutics Holdings' Free Cash Flow rose 2731.09% to -$17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$58.6 million, marking a year-over-year increase of 481.86%. This contributed to the annual value of -$60.4 million for FY2024, which is 18759.52% down from last year.
- According to the latest figures from Q3 2025, Arcturus Therapeutics Holdings' Free Cash Flow is -$17.3 million, which was up 2731.09% from -$5.8 million recorded in Q2 2025.
- Arcturus Therapeutics Holdings' 5-year Free Cash Flow high stood at $156.5 million for Q4 2022, and its period low was -$51.2 million during Q1 2022.
- For the 5-year period, Arcturus Therapeutics Holdings' Free Cash Flow averaged around -$13.4 million, with its median value being -$30.5 million (2024).
- Per our database at Business Quant, Arcturus Therapeutics Holdings' Free Cash Flow surged by 45871.15% in 2022 and then crashed by 50850.44% in 2025.
- Arcturus Therapeutics Holdings' Free Cash Flow (Quarter) stood at -$43.6 million in 2021, then surged by 458.71% to $156.5 million in 2022, then crashed by 100.96% to -$1.5 million in 2023, then skyrocketed by 81.12% to -$284000.0 in 2024, then tumbled by 6002.82% to -$17.3 million in 2025.
- Its Free Cash Flow stands at -$17.3 million for Q3 2025, versus -$5.8 million for Q2 2025 and -$35.3 million for Q1 2025.